Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11241 clinical trials
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors

Hepatic metastases are common in solid cancers (up to 30% of patients with colorectal cancer and up to 50% of patients during their follow-up). The incidence of primary liver cancer increases due to the increase in chronic liver diseases induced by excessive alcohol consumption, hepatitis B and C viruses, and …

hepatitis
skin cancer
liver cancer
chelates
metastasis
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of SGN-B6A in Advanced Solid Tumors

This trial will look at a drug called SGN-B6A to find out whether it is safe for people who have solid tumors. It will study SGN-B6A to find out what its side effects are. A side effect is anything the drug does besides treating cancer. It will also study whether …

measurable disease
solid tumour
cancer of the ovary
ovarian ca
pancreatic adenocarcinoma
  • 0 views
  • 05 Aug, 2020
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-na ve GBM Patients.

A multi-center, open-label, single-arm, phase I/II clinical study is designed to test the safety and immunogenicity of an investigational Dendritic and Glioma Cells Fusion vaccine given with IL-12 for treatment-nave patients after resection of glioblastoma.

glioblastoma multiforme
glioma
ejection fraction
blood cell count
white blood cell count
  • 0 views
  • 05 Aug, 2020
Progressive Resistance Training for Sarcoma Survivors

This trial studies how well progressive resistance training works in improving the physical function of sarcoma survivors. Treatments for sarcoma can cause side effects such as fatigue, muscle loss, and weakness, which can negatively impact a patient's ability to physically function and enjoy an independent lifestyle. Engaging in a resistance …

weakness
sarcoma
resistance training
residual tumor
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET

A Phase II trial aiming to assess the safety and activity of the combination of cabozantinib plus lanreotide in gastroenteropancreatic (GEP) and thoracic neuroendocrine tumor (NET): The LOLA trial

gilbert's syndrome
transient ischemic attack
clopidogrel
peripheral vascular disease
24-hour urine protein test
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Phase 1 Multi-Center Safety Dose Escalation Pharmacokinetics of INV-1120 in Adult Patients Advanced Solid Tumors

The safety, tolerability, and PK of INV-1120 will be assessed in adult patients with advanced solid tumors.

measurable disease
renal function test
solid neoplasm
renal function
solid tumour
  • 0 views
  • 16 Feb, 2024
  • 2 locations
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

This is a Phase II treatment, non-randomized, open label clinical trial to study the efficacy of the Cetuximab when administered as single agent in recurrent/ metastatic head and neck squamous cell carcinoma after the failure or intolerance of immuno-oncology or immuno-oncology combined with chemotherapy.

metastatic head and neck squamous cell cancer
metastatic squamous cell carcinoma
squamous cell carcinoma
cetuximab
measurable disease
  • 0 views
  • 05 Aug, 2020
A Study of SY 5609 a Selective CDK7 Inhibitor in Advanced Solid Tumors

This is a dose escalation study and will be the first to administer SY-5609 alone to humans with select advanced solid tumors and in combination with Fulvestrant to patients with HR positive, HER2-negative breast cancer.

metastatic breast cancer
her2/neu-negative breast cancer
measurable disease
hormone therapy
solid tumour
  • 0 views
  • 16 Feb, 2024
  • 5 locations
Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

This phase I trial studies how well cemiplimab before and after surgery works in treating patients with high risk cutaneous squamous cell cancer. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow …

monoclonal antibodies
neuropathy
hypothyroidism
hormone replacement therapy
oophorectomy
  • 0 views
  • 05 Aug, 2020
A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer

This study will evaluate the safety, tolerability, and pharmacokinetics of BLYG8824A and will make a preliminary assessment of the anti-tumor activity of BLYG8824A in patients with locally advanced or metastatic colorectal cancer.

fluoropyrimidine
monoclonal antibodies
metastatic colorectal cancer
measurable disease
oxaliplatin
  • 0 views
  • 05 Aug, 2020